The Pill Makers Next Door: How America’s Opioid Crisis Is Spreading

THE WALL STREET JOURNAL Oct. 5, 2016  SAN FRANCISCO—The married couple living in the third-floor, ocean-view apartment were friendly and ambitious. She explored the city, posting selfies on Facebook. He started a small music label at home. “They were nice people,” said Ann McGlenon, their former landlady. “She’s very sweet. He’s a go-getter.” Authorities say Candelaria Vazquez … Read more

Marijuana Not Conducive to Workplace Safety, DATIA Says

The DEA report affirming Schedule 1 Controlled Substance classification of marijuana shows clear evidence that marijuana is a drug causing impairment inconsistent with workplace safety. WASHINGTON, DC (PRWEB) SEPTEMBER 08, 2016 The U.S. Drug Enforcement Administration issued a report on Aug. 12, 2016 affirming the Schedule 1 Controlled Substance classification of marijuana after a scientific … Read more

Opioid-related insurance claims rose more than 3,000 percent 2007 to 2014

Source: CNBC.com Health insurance claims for people hooked on prescription painkillers and heroin skyrocketed as the number of Americans who fatally overdosed on those opioids hit record highs, a new analysis reveals. The number of private health insurance claims related to opioid dependence diagnosis soared by 3,204 percent from 2007 to 2014, the analysis found. The … Read more

FMCSA Annual Random Controlled Substances Testing Percentage Rate for Calendar Year 2016

The FMCSA announces, pursuant to 49 CFR 382.305, that it is reducing the minimum annual percentage rate for random controlled substances testing for drivers of commercial motor vehicles (CMVs) requiring a commercial driver’s license (CDL) from the current rate of 50 percent of the average number of driver positions to 25 percent of the average … Read more

US Drug Czar: Heroin Overdoses Are Top Concern of His Agency

WASHINGTON – Michael Botticelli, director of the Office of National Drug Control Policy, told a Congressional panel Wednesday that overdoses from heroin and prescription opioids is the most urgent concern facing his agency. “There is no more pressing issue,” said Botticelli, who testified at a House Oversight and Government Reform subcommittee hearing on the nation’s … Read more

Marijuana Use, Disorders Doubled Since 2001

NEW YORK (Reuters Health) – As attitudes and laws in the U.S. have become more tolerant of marijuana, the proportion of adults using and abusing the substance at least doubled between 2001 and 2013, according to a new study. Although marijuana dependence and abuse were found to be on the rise, that is largely due … Read more

How a Mysterious Synthetic Drug is Making Heroin Even More Deadly

Fentanyl is making heroin even more deadly The Washington Post Each tiny heroin bag was hand-stamped “Breaking Bad.” The name, a nod to the TV show about a teacher turned meth cook, was a colorful marketing ploy. And customers asked for it specifically. Demanded it, really. That tan powder was potent. Better than anything else … Read more

White House Drug Policy Office Funds New Projects in High Intensity Drug Trafficking Areas

Washington, D.C. – Today, Michael Botticelli, Director of National Drug Control Policy, announced $13.4 million in funding for High-Intensity Drug Trafficking Areas (HIDTA).  Of that, $5 million will be directed to a broad range of efforts that will reduce the trafficking, distribution, and use of heroin – a drug that has emerged as a serious … Read more

New Research Reveals the Trends and Risk Factors Behind America’s Growing Heroin Epidemic

Heroin use has increased across the United States among men and women, most age groups, and all income levels. The greatest increases have occurred in groups with historically lower rates of heroin use, including women and people with private insurance and higher incomes. In addition, nearly all people who use heroin also use multiple other … Read more

Psychemedics Announces Addition Of FDA Cleared Drugs

World’s largest hair drug testing company & scientific leader launches new screening tests for Oxymorphone and D-Amphetamine/Adderall®. ACTON, Mass., June 2, 2015 /PRNewswire/ — Psychemedics Corporation PMD, -0.06% hair testing pioneer and global leader for over twenty-five years, announced the addition of 2 new drugs to the company’s drug testing panels. In response to growing … Read more